NCT00650819View on ClinicalTrials.gov

Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

June 1, 2004

Primary Completion Date

February 1, 2005

Study Completion Date

February 1, 2005

Conditions

Hypercholesterolemia

Interventions

DRUG

Ezetimibe + Simvastatin

ezetimibe 10 mg plus simvastatin 20 mg once daily for 8 weeks

DRUG

Simvastatin

simvastatin 20 mg plus ezetimibe placebo once daily for 8 weeks

DRUG

Ezetimibe

Ezetimibe 10 mg plus simvastatin placebo once daily for 8 weeks

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00650819 - Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED) | Biotech Hunter | Biotech Hunter